Very interestingly, the combined blockade of IL-6 and PD-1/PD-L1 axe provides the synergistic effects not only on CD4+ Th1 response but also on the recruitment and function of CD8+ T cells in the tumor and its microenvironment [19, 20]. The gene discussed is IL6; the disease is neoplasm.